Regulatory Resources

Clinical guidelines, MDCG guidance, FDA guidance, standards, and compliance tools

Home/Resources
All Categories
American Guidelines 221 Annex XVI Products 3 Borderline and Classification 5 Brazil (ANVISA) 1 Cardiology & Vascular 19 Cardiology & Vascular 47 China (NMPA) 1 Class I Devices 1 Clinical Investigation and Evaluation 17 Dermatology & Venereology 12 Dermatology & Venereology 7 Endocrinology, Diabetes & Metabolism 19 Endocrinology, Diabetes & Metabolism 20 EU 3 EU Regulation 2 EUDAMED 2 European Guidelines 510 Eye, ENT & Neurosensory 5 Eye, ENT & Neurosensory 7 FDA Guidance 106 Gastroenterology & Hepatology 40 Gastroenterology & Hepatology 47 Imaging & Radiology 6 Imaging & Radiology 5 IMDRF Documents 115 India (CDSCO) 1 Infectious Diseases & Microbiology 31 Infectious Diseases & Microbiology 13 Internal Medicine & Emergency 14 Internal Medicine & Emergency 4 IVDR 2 Japan (PMDA) 1 MDCG Guidance 54 MDR 8 Medical Guidelines & Recommendations 731 Medical Technology & Engineering 0 Medical Technology & Engineering 0 NB White Papers 15 Neurology & Neurosurgery 56 Neurology & Neurosurgery 12 New Technologies 7 Notified Bodies 4 Oncology & Haematology 74 Oncology & Haematology 33 Other / Transition 5 Paediatrics 16 Paediatrics 6 Post-Market Surveillance and Vigilance 5 Public Health & Primary Care 39 Public Health & Primary Care 8 Regulations 17 Rehabilitation & Geriatrics 4 Rehabilitation & Geriatrics 15 Respiratory & Intensive Care 29 Respiratory & Intensive Care 8 Rheumatology & Immunology 29 Rheumatology & Immunology 11 South Korea (MFDS) 1 Standards 51 Surgery & Orthopaedics 5 Surgery & Orthopaedics 30 Team NB Documents 50 UDI 4 UK (MHRA) 1 Umbrella & Cross-Cutting 8 Umbrella & Cross-Cutting 0 US (FDA) 8 Women's Health & Obstetrics 33 Women's Health & Obstetrics 12
22 resources

FD&C Act — Federal Food, Drug, and Cosmetic Act

Regulation 2024-01-01 Regulations US (FDA)

The foundational US law authorizing FDA to regulate medical devices. Sections 513–520 govern device classification, premarket review, postmarket requirements, and enforcement.

Download PDF

France meeting outcome statement

IMDRF Outcome statement IMDRF Documents

Outcome statement published by IMDRF.

Download PDF

Florianópolis meeting outcome statement

IMDRF Outcome statement IMDRF Documents

Outcome statement published by IMDRF.

Download PDF

FOR GUIDANCE ONLY – IMDRF/MC/N69 FINAL:2023 (Edition 8): IMDRF Membership Application Form

IMDRF Procedural document 2023-10-31 IMDRF Documents

Procedural document published 2023 by IMDRF.

Download PDF

FDA Decisions for Investigational Device Exemption Clinical Investigations

FDA Guidance 2014-08-01 FDA Guidance

Final FDA guidance on ide. Published 2014 by CDRH/CBER.

Download PDF

Factors to Consider When Making Benefit-Risk Determinations for Medical Device IDEs

FDA Guidance 2017-01-01 FDA Guidance

Final FDA guidance on ide. Published 2017 by CDRH/CBER.

Download PDF

FDA and Industry Actions on 510(k) Submissions: Effect on FDA Review Clock and Goals

FDA Guidance 2017-10-01 FDA Guidance

Final FDA guidance on 510(k). Published 2017 by CDRH/CBER.

Download PDF

FDA and Industry Actions on PMA Submissions: Effect on FDA Review Clock and Goals

FDA Guidance 2017-10-01 FDA Guidance

Final FDA guidance on pma. Published 2017 by CDRH/CBER.

Download PDF

FDA Categorization of IDE Devices to Assist CMS with Coverage Decisions

FDA Guidance 2017-12-01 FDA Guidance

Final FDA guidance on ide. Published 2017 by CDRH/CBER.

Download PDF

Factors to Consider When Making Benefit-Risk Determinations in Medical Device Premarket Approval and De Novo

FDA Guidance 2019-08-01 FDA Guidance

Final FDA guidance on benefit-risk. Published 2019 by CDRH/CBER.

Download PDF
Loading more resources…
Scroll to Top